|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.95 USD | -2.75% |
|
-0.70% | +8.82% |
| Capitalization | 7.13B 6.08B 5.62B 5.29B 9.86B 663B 10.06B 65.96B 25.81B 319B 26.76B 26.2B 1,135B | P/E ratio 2026 * |
-23.4x | P/E ratio 2027 * | -21.2x |
|---|---|---|---|---|---|
| Enterprise value | 5.93B 5.05B 4.67B 4.4B 8.2B 551B 8.37B 54.84B 21.46B 265B 22.25B 21.78B 944B | EV / Sales 2026 * |
150x | EV / Sales 2027 * | 150x |
| Free-Float |
98.65% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kymera Therapeutics, Inc.
| 1 day | -2.90% | ||
| 1 week | -0.70% | ||
| Current month | +1.66% | ||
| 1 month | +0.11% | ||
| 3 months | +15.84% | ||
| 6 months | +48.00% | ||
| Current year | +8.82% |
| 1 week | 82.28 |  | 89.55 |
| 1 month | 73.31 | | 89.55 |
| Current year | 66.2 | | 95.9 |
| 1 year | 22.05 | | 103 |
| 3 years | 9.6 | | 103 |
| 5 years | 9.6 | | 103 |
| 10 years | 9.6 | | 103 |
| Manager | Title | Age | Since |
|---|---|---|---|
Nello Mainolfi
CEO | Chief Executive Officer | 47 | 31/10/2019 |
Bruce Jacobs
DFI | Director of Finance/CFO | 56 | 14/07/2019 |
Jeremy Chadwick
COO | Chief Operating Officer | 63 | 21/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Booth
CHM | Chairman | 51 | 31/07/2017 |
Nello Mainolfi
BRD | Director/Board Member | 47 | 31/10/2019 |
| Director/Board Member | 37 | 29/02/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.75% | -0.70% | +277.99% | +171.81% | 7.13B | |
| +1.74% | +2.39% | -1.27% | -9.59% | 44.74B | |
| -0.93% | +2.75% | +49.20% | +32.26% | 34.75B | |
| -0.89% | +1.53% | +34.43% | +36.72% | 29.82B | |
| -1.10% | -2.30% | +16.46% | -15.29% | 28.37B | |
| -0.64% | -0.30% | +182.37% | +362.88% | 19.07B | |
| -0.91% | +5.35% | +66.62% | +223.08% | 14.93B | |
| -2.43% | -1.37% | +73.27% | +156.46% | 14.32B | |
| +2.93% | -7.56% | +3,734.77% | +3,768.08% | 13.93B | |
| +0.25% | -1.35% | +37.01% | +2.59% | 13.17B | |
| Average | -0.48% | -0.82% | +447.09% | +472.90% | 22.02B | |
| Weighted average by Cap. | -0.20% | -0.72% | +286.79% | +306.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 39.61M 33.74M 31.23M 29.4M 54.77M 3.68B 55.89M 366M 143M 1.77B 149M 145M 6.3B | 40.95M 34.88M 32.28M 30.4M 56.62M 3.81B 57.78M 379M 148M 1.83B 154M 150M 6.52B |
| Net income | -353M -300M -278M -262M -488M -32.8B -498M -3.26B -1.28B -15.75B -1.32B -1.3B -56.12B | -405M -345M -319M -301M -560M -37.66B -571M -3.74B -1.47B -18.08B -1.52B -1.49B -64.43B |
| Net Debt | -1.2B -1.02B -948M -893M -1.66B -112B -1.7B -11.12B -4.35B -53.7B -4.51B -4.42B -191B | -988M -842M -779M -734M -1.37B -91.93B -1.39B -9.14B -3.58B -44.14B -3.71B -3.63B -157B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/04/26 | 84.80 $ | -2.91% | 116,435 |
| 09/04/26 | 87.35 $ | +0.25% | 510,044 |
| 08/04/26 | 87.13 $ | +2.39% | 514,352 |
| 07/04/26 | 85.10 $ | -0.20% | 359,754 |
| 06/04/26 | 85.27 $ | -0.15% | 434,157 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- KYMR Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition